Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
dTub
Скачать

Gilead CEO Daniel O'Day: Ending the HIV epidemic is our goal

Автор: CNBC Television

Загружено: 2023-01-09

Просмотров: 4106

Описание:

Gilead CEO Daniel O'Day joins 'Squawk Box' to discuss his outlook for the biopharma industry and more. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook:
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-cred...

#CNBC
#CNBCTV

Gilead CEO Daniel O'Day: Ending the HIV epidemic is our goal

Поделиться в:

Доступные форматы для скачивания:

Скачать видео mp4

  • Информация по загрузке:

Скачать аудио mp3

Похожие видео

Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV

Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV

Bristol-Myers CEO Says the Company Is in Transition

Bristol-Myers CEO Says the Company Is in Transition

Reagan Administration's Chilling Response to the AIDS Crisis

Reagan Administration's Chilling Response to the AIDS Crisis

Gilead Sciences CEO Daniel O'Day on the collaboration with biotech firm Galapagos

Gilead Sciences CEO Daniel O'Day on the collaboration with biotech firm Galapagos

4 Hours Chopin for Studying, Concentration & Relaxation

4 Hours Chopin for Studying, Concentration & Relaxation

Has the World Found a Cure for HIV? Vantage with Palki Sharma

Has the World Found a Cure for HIV? Vantage with Palki Sharma

Founder Stories: John Martin, Former CEO of Gilead Sciences

Founder Stories: John Martin, Former CEO of Gilead Sciences

⚡СРОЧНОЕ заявление Трампа о КОНЦЕ ВОЙНЫ! Требует НЕМЕДЛЕННЫХ ВЫБОРОВ в Украине.Зал ЗАТИХ после этого

⚡СРОЧНОЕ заявление Трампа о КОНЦЕ ВОЙНЫ! Требует НЕМЕДЛЕННЫХ ВЫБОРОВ в Украине.Зал ЗАТИХ после этого

Gilead CEO On 2024 drug pipeline: Expect results from around two dozen clinical trials

Gilead CEO On 2024 drug pipeline: Expect results from around two dozen clinical trials

Gilead Sciences to acquire Immunomedics in $21 billion deal

Gilead Sciences to acquire Immunomedics in $21 billion deal

The Covert Legal Strategy to Keep Your Drug Prices High

The Covert Legal Strategy to Keep Your Drug Prices High

An aggressive treatment for AIDS | 60 Minutes Archive

An aggressive treatment for AIDS | 60 Minutes Archive

Federal Reserve Chair Jerome Powell discusses third interest rate cut this year — 12/10/2025

Federal Reserve Chair Jerome Powell discusses third interest rate cut this year — 12/10/2025

How the AIDS Epidemic Played Part in NYC Party Girl's Death

How the AIDS Epidemic Played Part in NYC Party Girl's Death

Dr. Scott Gottlieb explains the potential of Gilead's coronavirus treatment

Dr. Scott Gottlieb explains the potential of Gilead's coronavirus treatment

Watch: President Trump Meets with CEO of Gilead | NBC News

Watch: President Trump Meets with CEO of Gilead | NBC News

HIV and growing old

HIV and growing old

The P/E Ratio For Gilead Stock Is WRONG...Here's Why!

The P/E Ratio For Gilead Stock Is WRONG...Here's Why!

50 Best of Chopin: Nocturnes, Études, Waltzes...

50 Best of Chopin: Nocturnes, Études, Waltzes...

Jim Cramer reacts to acquisitions from Nvidia, Gilead Sciences

Jim Cramer reacts to acquisitions from Nvidia, Gilead Sciences

© 2025 dtub. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]